Clinical trial
Effects of Modafinil on Brain Function in Patients With Schizophrenia
NCT00057707 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00057707 |
|---|---|
| Title | Effects of Modafinil on Brain Function in Patients With Schizophrenia |
| Official title | Randomized, Double-Blinded, Placebo Controlled Study of the Effects of Modafinil on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug, Procedure |
| Interventions | Modafinil, Functional MRI, Neuropsychological Testing |
| Enrollment | 176 |
| Start date | Mar 26, 2003 |
| Primary completion | Jun 16, 2017 |
| Completion | Jun 16, 2017 |
| First posted | Apr 7, 2003 |
| Last update posted | Dec 9, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: